Mirae Asset Global Investments Co., Ltd. Biomea Fusion, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,310 shares of BMEA stock, worth $10,715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,310
Previous 1,073
22.09%
Holding current value
$10,715
Previous $4,000
225.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BMEA
# of Institutions
119Shares Held
17.8MCall Options Held
978KPut Options Held
286K-
Cormorant Asset Management, LP Boston, MA3.57MShares$29.2 Million1.24% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$19.2 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$17.3 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$11.4 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.1MShares$9 Million0.01% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $240M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...